Lieff Cabraser Civil Justice Blog
Lieff Cabraser Attorneys Speak on Mass Tort Med School and Consumer Class Actions

Lieff Cabraser Attorneys Speak on Mass Tort Med School and Consumer Class Actions

Lieff Cabraser partners Annika K. Martin and Michael Miarmi will be featured as distinguished panelists at the Mass Tort Med School and Consumer Class Actions conferences in San Juan, Puerto Rico from May 3-5, 2016.

Ms. Martin will be participating on the Class Certification panel, which will discuss ascertainability, multi-state classes, issue classes, injury, harm and damages, and 23(b)(2) classes. Mr. Miarmi will be on the panel “Motion to Dismiss – What’s Trending?” with topics on standing, knowledge, and particularity. Other panel subject matters include recent updates from the U.S. Supreme Court and the Civil Rules Committee, MDL strategies, bellwether approaches, attorney’s fees, and the Class Action Fairness Act.

About Annika K. Martin

A partner in the firm’s New York office, Ms. Martin has represented plaintiffs in class action and mass tort litigation, including plaintiffs with physical and economic injuries resulting from accidents involving GM vehicles sold with a defective ignition switch; patients nationwide suffering from the widespread outbreak of meningitis and other serious maladies caused by contaminated medication; and individuals and businesses across the Gulf Coast harmed by the blowout on the Deepwater Horizon oil rig in class action litigation against BP, Transocean, and Halliburton.

About Michael Miarmi

Also a partner in the firm’s New York office, Michael Miarmi devotes his practice to representing individual and institutional investors in direct or class cases asserting claims under the federal securities laws or state law. He has been an actively involved member of the team serving as co-lead counsel for the proposed customer class in In re Bank of New York Mellon Corp. Foreign Exchange Transactions Litigation, Arkansas Teacher Retirement System v. State Street Corp., and counsel for The Charles Schwab Corporation and its entities in litigation arising from alleged fraud by financial institutions setting the London InterBank Offered Rate (LIBOR).